Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-044561

President and CEO sold 2,314 shares at $4.48 ($10,367)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-04 Sale : show line 1 in the form −2,314 $4.48 $10,367 626,477 D
Open-market sales · 2,314 sh · avg $4.48 · $10,367
Loading xslF345X03/doc4.xml…